|
Volumn 19, Issue 9, 2011, Pages 2888-2902
|
Synthesis, in silico docking experiments of new 2-pyrrolidinone derivatives and study of their anti-inflammatory activity
|
Author keywords
2 Pyrrolidinones; Anti inflammatory activity; LOX
|
Indexed keywords
(1H IMIDAZOL 1 YLMETHYL) 1 (PHENYLMETHYL) 2 PYRROLIDINONE;
(1H IMIDAZOL 1 YLMETHYL) 1 [[2 [1 (PHENYLMETHYL) 1H 1,2,3,4 TETRAZOL 5 YL]PHENYL]METHYL] 2 PYRROLIDINONE;
(1H IMIDAZOL 1 YLMETHYL) 1 [[3 (PHENYLMETHOXY)PHENYL]METHYL] 2 PYRROLIDINONE;
(HYDROXYMETHYL) 1 (PHENYLMETHYL) 2 PYRROLIDINONE;
(HYDROXYMETHYL) 1 [[2 [1 (PHENYLMETHYL) 1H 1,2,3,4 TETRAZOL 5 YL]PHENYL]METHYL] 2 PYRROLIDINONE;
(HYDROXYMETHYL) 2 PYRROLIDINONE;
1 [(3 HYDROXYPHENYL)METHYL] (1H IMIDAZOL 1 YLMETHYL) 2 PYRROLIDINONE;
1H IMIDAZOLE 4 (5) CARBOXYLIC ACID, 1 [[5 OXO 1 (PHENYLMETHYL) PYRROLIDINYL]METHYL], PHENYLMETHYL ESTER;
1H IMIDAZOLE 4 CARBOXYLIC ACID, 1 [[1 [[4 (METHOXYCARBONYL)PHENYL]METHYL] 5 OXO PYRROLIDINYL]METHYL],PHENYLMETHYL ESTER;
1H IMIDAZOLE 4 CARBOXYLIC ACID, 1 [[1 [[4 (METHOXYCARBONYL)PHENYL]METHYL] 5 OXO PYRROLIDINYL]METHYL];PHENYLMETHYL ESTER;
2 PYRROLIDINECARBOXYLIC ACID, 5 OXO 1 [[2 [1 (PHENYLMETHYL) 1H 1,2,3,4 TETRAZOL 5 YL]PHENYL]METHYL]METHYL ESTER;
2 PYRROLIDINONE, (1H IMIDAZOL 1 YLMETHYL) 1 [[2 (1H 1,2,3,4 TETRAZOL 5 YL)PHENYL]METHYL];
2 PYRROLIDONE DERIVATIVE;
5 [[(TRIETHYLSILYL)OXY]METHYL] 2 PYRROLIDINONE;
ACETIC ACID, (5 OXO 2 PYRROLIDINYL)METHYL ESTER;
BENZENESULFONIC ACID, 4 METHYL, [5 OXO 1 (PHENYLMETHYL) PYRROLIDINYL]METHYL ESTER;
BENZENESULFONIC ACID, 4 METHYL, [5 OXO 1 [[2 [1 (PHENYLMETHYL) 1H 1,2,3,4 TETRAZOL 5 YL]PHENYL]METHYL] 2 PYRROLIDINYL]METHYL ESTER;
BENZOIC ACID, 4 [[(1H IMIDAZOL 1 YLMETHYL) 5 OXO 1 PYRROLIDINYL]METHYL],METHYL ESTER;
BENZOIC ACID, 4 [[(1H IMIDAZOL 1 YLMETHYL) 5 OXO 1 PYRROLIDINYL]METHYL],PHENYLMETHYL ESTER;
BENZOIC ACID, 4 [[2 (HYDROXYMETHYL) 5 OXO 1 PYRROLIDINYL]METHYL],METHYL ESTER;
BENZOIC ACID, 4 [[2 (HYDROXYMETHYL) 5 OXO 1 PYRROLIDINYL]METHYL],PHENYLMETHYL ESTER;
BENZOIC ACID, 4 [[2 [(ACETYLOXY)METHYL] 5 OXO 1 PYRROLIDINYL]METHYL],METHYL ESTER;
BENZOIC ACID, 4 [[2 [[[(4 METHYLPHENYL)SULFONYL]OXY]METHYL] 5 OXO 1 PYRROLIDINYL]METHYL],PHENYLMETHYL ESTER;
BENZOIC ACID, 4 [[2 OXO 5 [[(TRIETHYLSILYL)OXY]METHYL] 1 PYRROLIDINYL]METHYL],PHENYLMETHYL ESTER;
INDOMETACIN;
METHYL 1 [(1,4 [(BENZYLOXY)CARBONYL]BENZYL 5 OXOTETRAHYDRO 1H PYRROL 2 YL)METHYL] 1H IMIDAZOLE 4 CARBOXYLATE;
METHYL 1 [(1,4 [(BENZYLOXY)CARBONYL]BENZYL 5 OXOTETRAHYDRO 1H PYRROL 2 YL)METHYL] 1H IMIDAZOLE 5 CARBOXYLATE;
PYRROLIDINECARBOXYLIC ACID, 5 OXO 1 [[3 (PHENYLMETHOXY)PHENYL]METHYL],METHYL ESTER;
PYRROLIDINECARBOXYLIC ACID,5 OXO 1 (PHENYLMETHYL)METHYL ESTER;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIINFLAMMATORY ACTIVITY;
ANTIOXIDANT ACTIVITY;
ARTICLE;
CATALYSIS;
COMPUTER MODEL;
CONTROLLED STUDY;
CRYSTAL STRUCTURE;
DRUG DESIGN;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME ACTIVE SITE;
ENZYME INHIBITION;
HYDROGEN BOND;
IC 50;
LIPID PEROXIDATION;
MOLECULAR DOCKING;
NONHUMAN;
PAW EDEMA;
RAT;
REACTION TIME;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
BINDING SITES;
CATALYTIC DOMAIN;
COMPUTER SIMULATION;
EDEMA;
IMIDAZOLES;
LIPOXYGENASES;
PYRROLES;
PYRROLIDINONES;
RATS;
RATTUS;
|
EID: 79955420758
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2011.03.044 Document Type: Article |
Times cited : (27)
|
References (47)
|